CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-11
DOI
10.1038/s41598-020-79321-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
- (2019) Yong Le et al. Cancer Cell International
- circFADS2 regulates lung cancer cells proliferation and invasion via acting as a sponge of miR-498
- (2018) Fucheng Zhao et al. BIOSCIENCE REPORTS
- circRNAs in Cancer
- (2018) Ines Lucia Patop et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- A circRNA–miRNA–mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma
- (2018) Dan-dan Xiong et al. Journal of Translational Medicine
- Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression
- (2017) Dan Han et al. HEPATOLOGY
- circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
- (2017) Rongfang He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Recurrently deregulated lncRNAs in hepatocellular carcinoma
- (2017) Yang Yang et al. Nature Communications
- Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma
- (2017) Xiu-Yan Huang et al. Scientific Reports
- GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
- (2016) Mihwa Kim et al. Autophagy
- Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma
- (2016) Meilin Qin et al. Cancer Biomarkers
- LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p
- (2016) Wei Nie et al. CANCER LETTERS
- Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
- (2016) Ran Xu Zhu et al. Gut and Liver
- Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma
- (2016) Mansi A. Parasramka et al. PHARMACOLOGY & THERAPEUTICS
- A long non-coding RNA interacts with Gfra1 and maintains survival of mouse spermatogonial stem cells
- (2016) L Li et al. Cell Death & Disease
- Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs
- (2016) Qiupeng Zheng et al. Nature Communications
- LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway
- (2016) Shi-Peng Li et al. Oncotarget
- MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells
- (2015) Ruonan Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Downregulation of microRNA-498 in colorectal cancers and its cellular effects
- (2015) Vinod Gopalan et al. EXPERIMENTAL CELL RESEARCH
- Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway
- (2015) Feng Wang et al. Oncotarget
- LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
- (2015) Haibing Xiao et al. Oncotarget
- Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis and normal human tissues
- (2015) Anna Bachmayr-Heyda et al. Scientific Reports
- Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients
- (2014) CHAOFENG DING et al. Oncology Letters
- Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Donald Poon et al. LANCET ONCOLOGY
- HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma
- (2008) Man–Fung Yuen et al. GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- A Single SR-like Protein, Npl3, Promotes Pre-mRNA Splicing in Budding Yeast
- (2008) Tracy L. Kress et al. MOLECULAR CELL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started